2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Knee Bursitis Market?

The knee bursitis market is predicted to grow due to the escalating occurrence of diseases related to bones. Such bone-related ailments include osteoporosis, arthritis, and bone cancer, impacting the skeletal system’s design, robustness, and function. The rise in these conditions is credited to elements such as growing elderly population, inactive way of life, inadequate nutrition, and changing environments. Diseases related to bones, such as osteoarthritis and rheumatoid arthritis, might result in knee bursitis by provoking inflammation and excessive strain on the knee bursa. This inflammation leads to pain, swelling, and a diminished joint function. A report by Healthy Bones Australia, a non-profit organization in Australia, projected in September 2022 that an estimate of 6.2 million individuals aged 50 and up in Australia would be suffering from osteoporosis or osteopenia in 2022. This estimate is based on the fact that 22% have osteoporosis and 78% have osteopenia among the 4.74 million Australians with poor bone health. Therefore, the increasing incidence of bone-related health conditions is propelling the growth of the knee bursitis market. The growth of the knee bursitis market is anticipated to be fueled by the rising diabetic population. Diabetes, which is a chronic disease where the body’s inability to regulate blood sugar levels, is often caused by insufficient insulin production or ineffective use of insulin. The rise in diabetic cases is attributed to factors such as inactive lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetes patients can develop knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. A report by the National Health Service (NHS) showed that as of June 2024, the number of people registered with pre-diabetes increased to 3,615,330 in 2023, a rise of 18% from 3,065,825 in 2022. Hence, the increasing diabetic population is propelling the growth of the knee bursitis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

How Has the Knee Bursitis Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

There has been significant growth in the market size for knee bursitis in the past years. The market is projected to expand from $2.66 billion in 2024 to $2.86 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The market expansion during the historic period can be credited to factors such as the aging population, a rise in engagement in sports and physical activities, advancements in diagnostic methods, better access to healthcare services, and educational initiatives for both healthcare providers and patients.

We anticipate substantial expansion in the knee bursitis market in the upcoming years. By 2029, it’s projected to soar to $3.79 billion with a compound annual growth rate (CAGR) of 7.3%. The forecast period’s escalation can be linked to heightened consciousness campaigns around prevention and administration, increased disposable income, upticks in healthcare expenditure, and a surge in recognition and diagnosis of knee bursitis. Major movements expected during the forecast period cover advancements in diagnostic methods, the emergence of new therapies, progress in research and development undertakings, as well as the rise of telemedicine and remote tracking.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

Who Are the Top Companies Driving Innovation and Growth in theKnee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Key Market Segments Comprise the Knee Bursitis Market and Drive Its Revenue Growth?

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Imaging Test, Other Diagnosis Tests

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound

2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Which Regions Are Emerging as Leaders in the Knee Bursitis Market?

North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Knee Bursitis Market 2025, By The Business Research Company:

Medical Devices Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-devices-reimbursement-global-market-report

Healthcare Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

1, 4 Butanediol Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/1-4-butanediol-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: